Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Depreciation & Amortization - Total (2018 - 2025)

Health Catalyst's Depreciation & Amortization - Total history spans 8 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization - Total rose 21.21% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $15.0 million, up 17.19%, while the annual FY2025 figure was $15.0 million, 17.19% up from the prior year.
  • Depreciation & Amortization - Total reached $4.0 million in Q4 2025 per HCAT's latest filing, up from $3.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $4.0 million in Q4 2025 to a low of $700000.0 in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $2.8 million, with a median of $3.1 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization - Total: soared 228.57% in 2022, then dropped 3.12% in 2023.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $2.0 million in 2021, then surged by 60.0% to $3.2 million in 2022, then decreased by 3.12% to $3.1 million in 2023, then grew by 6.45% to $3.3 million in 2024, then grew by 21.21% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Depreciation & Amortization - Total are $4.0 million (Q4 2025), $3.8 million (Q3 2025), and $3.6 million (Q2 2025).